Gurklis J - Search Results

1

Platelet aggregation and dense granule secretion in schizophrenia.

Yao JK, van Kammen DP, Gurklis J, Peters JL. Yao JK, et al. Among authors: gurklis j. Psychiatry Res. 1994 Oct;54(1):13-24. doi: 10.1016/0165-1781(94)90061-2. Psychiatry Res. 1994. PMID: 7701025

2

CSF chromogranin A-like immunoreactivity in schizophrenia: relationships with REM latency and slow wave sleep.

van Kammen DP, O'Connor DT, Neylan TC, Mouton A, Gurklis JA, Gilbertson MW, Peters JL. van Kammen DP, et al. Among authors: gurklis ja. Psychiatry Res. 1992 Apr;42(1):53-63. doi: 10.1016/0165-1781(92)90038-5. Psychiatry Res. 1992. PMID: 1603881

3

Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.

van Kammen DP, Kelley ME, Gurklis JA, Gilbertson MW, Yao JK, Peters JL. van Kammen DP, et al. Among authors: gurklis ja. Arch Gen Psychiatry. 1995 Aug;52(8):673-8. doi: 10.1001/archpsyc.1995.03950200063015. Arch Gen Psychiatry. 1995. PMID: 7543265

4

Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic-free.

Nofzinger EA, van Kammen DP, Gilbertson MW, Gurklis JA, Peters JL. Nofzinger EA, et al. Among authors: gurklis ja. Biol Psychiatry. 1993 Jun 1-15;33(11-12):829-35. doi: 10.1016/0006-3223(93)90024-8. Biol Psychiatry. 1993. PMID: 8104041 Clinical Trial.

5

Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia.

Yao JK, van Kammen DP, Gurklis JA. Yao JK, et al. Among authors: gurklis ja. Psychiatry Res. 1996 Feb 28;60(1):11-21. doi: 10.1016/0165-1781(95)02832-3. Psychiatry Res. 1996. PMID: 8852864

6

Predicting haloperidol treatment response in chronic schizophrenia.

van Kammen DP, Kelley ME, Yao JK, Gilbertson MW, Gurklis JA, Inosaka T, Saito H, Peters JL, Sato M. van Kammen DP, et al. Among authors: gurklis ja. Psychiatry Res. 1996 Aug 30;64(1):47-58. doi: 10.1016/0165-1781(96)02906-x. Psychiatry Res. 1996. PMID: 8888364 Clinical Trial.

7

Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients.

van Kammen DP, Kelley ME, Gurklis JA, Gilbertson MW, Yao JK, Condray R, Peters JL. van Kammen DP, et al. Among authors: gurklis ja. Neuropsychopharmacology. 1996 Apr;14(4):275-83. doi: 10.1016/0893-133X(95)00135-Z. Neuropsychopharmacology. 1996. PMID: 8924195

8

Chronic haloperidol treatment does not affect structure of attention in schizophrenia.

Allen DN, Gilbertson MW, van Kammen DP, Kelley ME, Gurklis JA Jr, Barry EJ. Allen DN, et al. Among authors: gurklis ja jr. Schizophr Res. 1997 May 3;25(1):53-61. doi: 10.1016/s0920-9964(97)00006-6. Schizophr Res. 1997. PMID: 9176927

9

Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia.

van Kammen DP, Poltorak M, Kelley ME, Yao JK, Gurklis JA, Peters JL, Hemperly JJ, Wright RD, Freed WJ. van Kammen DP, et al. Among authors: gurklis ja. Biol Psychiatry. 1998 May 1;43(9):680-6. doi: 10.1016/s0006-3223(97)00324-7. Biol Psychiatry. 1998. PMID: 9583002 Clinical Trial.

10

GABA and brain abnormalities in schizophrenia.

van Kammen DP, Petty F, Kelley ME, Kramer GL, Barry EJ, Yao JK, Gurklis JA, Peters JL. van Kammen DP, et al. Among authors: gurklis ja. Psychiatry Res. 1998 Apr 10;82(1):25-35. doi: 10.1016/s0925-4927(98)00006-7. Psychiatry Res. 1998. PMID: 9645548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters